Corporate Governance コーポレート・ガバナンス

TopSustainabilityCorporate Governance

Related SDGs

JCR is strengthening corporate governance for sustainable corporate value creation.

Corporate Governance

JCR Group considers that for the purpose of providing superior quality and more useful pharmaceutical products and medical equipment to society, it is important to aim to enhance the legality, transparency and objectivity of the Company’s management, to heighten our corporate value further, and at the same time to build a system to ensure the protection of the interests of shareholders. For this purpose, we are putting forth effort to secure implementation and operation of effective internal control systems, to evaluate the effectiveness of such systems on our own, and to fulfill social responsibilities as a corporation.
JCR is a company with an Audit & Supervisory Board. As such, we have established the Board of Directors consisting of 11 Directors, including six Outside Directors, the Audit & Supervisory Board consisting of five Outside Audit & Supervisory Board Members, and Accounting Auditors. In addition to these organs, we have established the Management Control Committee, Advisory Committee for Nomination, Compensation, Etc., Sustainability Advisory Committee, Management Committee, Internal Audit Department, Internal Control Committee, Compliance Committee, Sustainability Committee, Safety and Health Committee, Environmental Committee, Donation Screening Committee, and Risk Management Promotion Meeting. As for the composition of the corporate governance system we believe the corporate governance system covers an appropriate scope in line with our current condition, and that it enables efficient management of business operations. Also, we have judged that the current governance system, which includes six Outside Directors and five Outside Audit & Supervisory Board Members, is effective for ensuring management transparency, objectivity (impartiality) and independent supervision over management.

Please refer to “Corporate Governance” for details.

Compliance

For the purpose of compliance, we recognize that it is important to adhere to laws and regulations, global standards, and various industrial standards, and also to foster a corporate culture with a heightened sense of ethics in the course of day-to-day corporate activities. JCR has established a Compliance Committee as an organization to implement and promote company management in line with social norms and corporate ethics as well as compliance with laws and regulations. The Committee consists of two sub-committees: a Compliance Control Committee chaired by the Senior Vice President and Chief Compliance Officer, with committee members including our Directors and Corporate Officers, as well as external experts; and a Compliance Promotion Committee comprising employees nominated by the Compliance Control Committee members and assigned by the President. To promote compliance at JCR, the Compliance Committee holds meetings on a regular basis, determines the Company’s compliance action plans and policies, and provides employee training and education in accordance with the Compliance Code of Conduct and the Compliance Manual, along with making compliance matters more widely known and raising awareness through a compliance newsletter.

Please refer to “Compliance” for details.

Risk Management

As a company that handles pharmaceutical products that concern people’s health, JCR has established procedures for risk control in each of its divisions along with ascertaining risk in business activities. It also determines basic risk management guidelines and develops its risk management system based on those guidelines. Furthermore, JCR is creating systems to address risk prevention, risk management, and risk contingencies through collaboration with related committees such as the Risk Management Promotion Office, Internal Control Committee and Compliance Committee.
JCR has listed the important risks it should be aware of and selected and decided on the three items below as BCP priorities. The BCP is reviewed each fiscal year and revised if needed.

In particular, as a pharmaceutical company, JCR regularly holds meetings of the three executives of manufacturing and marketing (Marketing Supervisor-General, Quality Assurance Manager, and Safety Management Supervisor) in accordance with laws and regulations, and has constructed systems that assure the quality, effectiveness and safety of drugs.
Moreover, while expanding its operations globally, JCR will introduce a world-class drug quality system and pursue an even higher level of safety.

Risk Management System